During the 1980s, there was evidence of a sharp increase in the rate of cerebral palsy among babies with a birthweight of less than 1500 g. This is thought to reflect an increase in their survival. ' The increased cerebral palsy rate might reflect the survival of babies who have sustained a cerebral insult in utero and were born preterm, or alternatively, the survival of immature babies who are particularly vulnerable to haemorrhage and ischaemia in the intrapartum and neonatal period.2 A third possibility is that cerebral palsy in very preterm babies is the endpoint of a continuum of adverse events which occur throughout the period when the developing white matter is particularly vulnerable to injury-that is, 26-34 weeks of gestation. These adverse events might occur before, during, or after birth.
The available ways of assessing the time of brain injury are limited. Because of the well F27 described association between cystic lesions detected on cerebral ultrasonography and subsequent cerebral palsy, " neuroimaging around or after the time of birth provides one way of estimating when cerebral palsy arises. Occasionally, antenatal neuroimaging can demonstrate severe and well established cystic white matter lesions that have arisen before birth.8 More frequently, lesions are first detected by neuroimaging of the infant brain after birth. Some of the lesions detected in this way have clearly been present before birth,8'-0 but more frequently, the lesions are first seen days or weeks after birth. The early changes following an ischaemic insult, however, may not be detected by current methods of cranial ultrasound, and this places a severe constraint on this method as a means of timing the onset of brain lesions with any precision.
An alternative approach is to study the time of onset of cerebral lesions seen on neuropathological study in babies who die. Ischaemic white matter lesions, cerebral malformations, hydrocephalus following intraventricular haemorrhage, and cerebral infection can all be clearly defined at necropsy, and when they occur, can be estimated with reasonable certainty. Babies with any of these conditions, had they survived, might have shown signs of cerebral palsy. Indeed, study of the brains of children with cerebral palsy who die shows that a proportion have white matter damage of varying severity which could plausibly be the end result of the ischaemic white matter lesions seen on perinatal neuropathological study (unpublished data). In a previous neuropathological study of the prevalence and characteristics of cerebral lesions in babies of all gestational ages who either die in utero or early in the neonatal period, the commonest lesion was ischaemic white matter injury." A proportion of these ischaemic lesions occurred prenatally. In view of the likely association between these ischaemic white matter lesions in babies who die and the lesions which are precursors of cerebral palsy in babies who survive, we studied the brains of very preterm singleton babies who die during their first hospital admission. The following questions were addressed. What is the prevalence of white matter lesions in very preterm babies who die and the clinical factors associated with the lesions? Do the clinical factors, which are associated with lesions of prenatal origin, differ from those associated with lesions of postnatal origin? We also wanted to explore the relation between (n(%)) Baseline characteristics at birth were similar for those with and without ischaemic white matter damage, and although there was a higher proportion of males and congenital abnormalities among babies with no lesions, and a higher proportion of small for gestational age babies among those with lesions, these differences were not significant at the 5% level (table 2) . However, babies with ischaemic lesions died earlier than babies with no lesions (P= 0.005).
There were no significant differences in the numbers of adverse antenatal events when comparing those with and without ischaemic lesions ( 1 -18) ), necrotising enterocolitis (odds ratio 25 (2.5 -248)), and seizures (odds ratio 24 (3.8 -108)) were associated with an increased risk of postnatal white matter damage. Ultrasound scans were available for 21 (58%) of the subjects with no lesions and 30 (77%) of the subjects with ischaemic lesionsseven (58%) prenatal subjects and 10 (83%) postnatal subjects (table 6). The identification of lesions was reasonably consistent when ultrasound and necropsy findings were compared. Only one of the 21 cases without lesions appeared to have a parenchymal lesion on ultrasound which was not confirmed at necropsy. Of the 30 infants scanned who had ischaemic white matter at necropsy, 22 had parenchymal lesions, eight hydrocephalus, and two were normal. Five of the seven cases with prenatal white matter damage had lesions detected by ultrasound in the first nine days of life. Six of the 10 cases with postnatal white matter damage had lesions detected by ultrasound; three in the first nine days of life and three after the ninth day of life.
Discussion
There was neuropathological evidence of cerebral damage in 57% of babies examined; in 83% these were white matter ischaemic lesions. In view of the site and characteristics of these lesions, it is plausible that, had they survived, they might have shown signs of cerebral palsy. This observation supports the overall view that the increasing rate and numbers of surviving very preterm babies with cerebral palsy reflects the survival of children with ischaemic white matter damage.' Furthermore, in our study there was evidence that a third of the ischaemic lesions were of prenatal origin. This is consistent with findings in previous studies" '4 '5 and lends indirect support to the view that survivors who have sustained an in utero insult may contribute to the increased numbers of preterm babies with cerebral palsy.
Although the neuropathological examination clearly demonstrated prenatal ischaemic lesions, these were not associated with detectable antenatal clinical events. In previous studies clinical factors such as intrauterine growth retardation, oligohydramnios, and maternal infection have been associated with the development of prenatal ischaemic lesions.""'7 Although adverse antenatal factors were common in the mothers of babies in this study, there were no clear differences between the prevalence of antenatal events in babies with and without prenatal lesions. The increased prevalence of delivery without labour among those with prenatal lesions may reflect an association with the underlying reasons for elective caesarean section, such as pre-eclampsia and intrauterine growth retardation. But the numbers were small and this finding could be attributed to chance.
It remains a possibility that prenatal ischaemic injury is triggered by factors which we did not consider, or Meanwhile the observation that adverse antenatal events are associated with postnatal ischaemic lesions not only highlights the problem of relating the time of brain injury to the clinical findings, but also raises the possibility of a cascade of adverse events originating in the prenatal period and culminating in ischaemia in the brain and other organs after birth. Indeed, the view that cerebral ischaemic lesions are either prenatal or postnatal in origin may be rather simplistic. Biological studies suggest that the period in which the developing white matter is most vulnerable to hypoxicischaemic injury is from 26 to 34 weeks of gestation.2' Very preterm babies may be delivered at any point during this critical period and the effect of ischaemic damage needs to be related not so much to the event of birth as to the gestational age of the fetus or baby when an insult occurs. Perhaps we need to focus more on the response of an immature brain to a variety of insults which may occur at any point in this vulnerable period, and less on a polarised debate about the prenatal or postnatal origins of cerebral palsy. This theory is supported by experimental studies in fetal lambs where several short insults have been shown to produce more brain damage than one single insult of similar overall duration. 22 Finally, there will always be concerns about the association between the ischaemic lesions seen at necropsy and those which are precursors of cerebral palsy in survivors. Advances in neuroimaging seem to offer the most promising way forward in identifying and timing the onset of cerebral ischaemic lesions in liveborn babies. Ultrasound scans detected parenchymal lesions in 73% of the babies with white matter damage at necropsy and the estimated time of onset of the lesions was consistent between the two investigations. At present, postnatal ultrasonography is the most widely used method of determining the presence and time of onset of these lesions in living babies. Newer methods of brain imaging such as magnetic resonance imaging (MRI) are now being introduced and may improve the sensitivity and specificity of detecting ischaemic lesions in the fetus and the newborn baby.
